507 related articles for article (PubMed ID: 31466350)
1. Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes.
I S Sobczak A; A Blindauer C; J Stewart A
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31466350
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.
Carmena R
Am Heart J; 2005 Nov; 150(5):859-70. PubMed ID: 16290951
[TBL] [Abstract][Full Text] [Related]
3. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden G; Chen X
Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus.
Spiller S; Blüher M; Hoffmann R
Diabetes Obes Metab; 2018 Nov; 20(11):2661-2669. PubMed ID: 29943387
[TBL] [Abstract][Full Text] [Related]
5. Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.
Lv ZH; Ma P; Luo W; Xiong H; Han L; Li SW; Zhou X; Tu JC
BMC Cardiovasc Disord; 2014 Nov; 14():159. PubMed ID: 25399059
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus.
Reyes-Soffer G; Rondon-Clavo C; Ginsberg HN
Expert Opin Pharmacother; 2011 Jun; 12(9):1429-38. PubMed ID: 21426238
[TBL] [Abstract][Full Text] [Related]
7. Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.
Zhang MH; Cao YX; Wu LG; Guo N; Hou BJ; Sun LJ; Guo YL; Wu NQ; Dong Q; Li JJ
BMC Endocr Disord; 2020 Oct; 20(1):156. PubMed ID: 33087077
[TBL] [Abstract][Full Text] [Related]
8. Plasma Free Fatty Acid Concentration as a Modifiable Risk Factor for Metabolic Disease.
Henderson GC
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444750
[TBL] [Abstract][Full Text] [Related]
9. Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.
Wolf P; Winhofer Y; Krssak M; Smajis S; Harreiter J; Kosi-Trebotic L; Fürnsinn C; Anderwald CH; Baumgartner-Parzer S; Trattnig S; Luger A; Krebs M
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):387-92. PubMed ID: 27118107
[TBL] [Abstract][Full Text] [Related]
10. Elevated Plasma Free Fatty Acid Susceptible to Early Cognitive Impairment in Type 2 Diabetes Mellitus.
Zhu W; Xu L; Zhang H; Tian S; An K; Cao W; Shi J; Tang W; Wang S
J Alzheimers Dis; 2021; 82(3):1345-1356. PubMed ID: 34151809
[TBL] [Abstract][Full Text] [Related]
11. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076
[TBL] [Abstract][Full Text] [Related]
12. Nutritional effects of fat on carbohydrate metabolism.
Boden G; Carnell LH
Best Pract Res Clin Endocrinol Metab; 2003 Sep; 17(3):399-410. PubMed ID: 12962693
[TBL] [Abstract][Full Text] [Related]
13. Effect of augmented glycation in mobilization of plasma free fatty acids in type 2 diabetes mellitus.
Chandra K; Jain V; Azhar M; Khan W; Alam O; Ahmad S; Jain SK
Diabetes Metab Syndr; 2020; 14(5):1385-1389. PubMed ID: 32755839
[TBL] [Abstract][Full Text] [Related]
14. Advances in free fatty acid profiles in gestational diabetes mellitus.
Du H; Li D; Molive LM; Wu N
J Transl Med; 2024 Feb; 22(1):180. PubMed ID: 38374136
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.
Boden G; Shulman GI
Eur J Clin Invest; 2002 Jun; 32 Suppl 3():14-23. PubMed ID: 12028371
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Bilz S
Ther Umsch; 2017; 74(8):445-453. PubMed ID: 29461147
[No Abstract] [Full Text] [Related]
17. Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin.
Arnaboldi L; Corsini A
Atheroscler Suppl; 2015 Jan; 16():1-27. PubMed ID: 25575403
[TBL] [Abstract][Full Text] [Related]
18. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes.
Kashyap SR; Belfort R; Berria R; Suraamornkul S; Pratipranawatr T; Finlayson J; Barrentine A; Bajaj M; Mandarino L; DeFronzo R; Cusi K
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E537-46. PubMed ID: 15126243
[TBL] [Abstract][Full Text] [Related]
19. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes.
Boden G
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183
[TBL] [Abstract][Full Text] [Related]
20. Plasma Free Fatty Acids Metabolic Profile Among Uyghurs and Kazaks With or Without Type 2 Diabetes Based on GC-MS.
Ma XL; Meng L; Li LL; Ma LN; Mao XM
Exp Clin Endocrinol Diabetes; 2018 Nov; 126(10):604-611. PubMed ID: 29117617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
